Navigation Links
Genos receives CAP Accreditation for Meeting the Highest Standards in Laboratory Practices

SAN FRANCISCO, Feb. 16, 2017 /PRNewswire/ -- Genos, a community for personal genetic discovery and research, today announced that it has received Laboratory Accreditation from the College of American Pathologists (CAP). The CAP Accreditation is presented to laboratories that meet stringent requirements around quality, accuracy and consistency and who demonstrate scientifically rigorous processes.

"Genos is committed to maintaining the highest standards of excellence in laboratory practices. We're honored to be receiving CAP accreditation," said Jill MacAfee, CLS, Director of Laboratory Operations at Genos.

"The CAP accreditation helps demonstrate Genos' commitment to the quality and the accuracy of its data for purposes of its Impact Network that connects researchers with high-quality genomic and phenotypic data," said Arthur Baca, M.D., Ph.D., Laboratory Director of Genos. "With this accomplishment under its belt, Genos will continue to grow its community of sequenced individuals and enable acceleration of research initiatives."

Genos' platform launched in December 2016 to offer exome sequencing and empower individuals to participate in groundbreaking research projects on their own terms through the Impact Network. The initial set of research partners include, NantBioScience, NantKwest, Broad Institute, and the Utah Foundation for Biomedical Research.

About the College of American Pathologists
As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, visit

About Genos
Genos is a crowdsourcing platform for genomics research and discovery. The company's mission is to break down the barriers to accelerate disease research and medical cures. The Genos community democratizes access to comprehensive personal discovery through DNA, and empowers individuals to retain ownership of their genetic data and consent in the research process. Genos is backed by strategic investors with deep roots in healthcare and technology, and the company's advisors include luminaries in genetics, economics, and consumer technology. For more information, or to help crowdsource cures on your terms, please visit

Media Contacts

McKenzie Haggard
Method Communications
(801) 461-9773


To view the original version on PR Newswire, visit:

Copyright©2017 PR Newswire.
All rights reserved

Related biology news :

1. Carnegies Chris Field receives Max Planck Research Prize
2. VCU receives NIH grant to examine the biology of allergic disease
3. Wayne State receives NSF grant to develop plan for field-based water research center
4. SmartMove, Inc. receives $200,000 grant from the Colorado Office of Economic Development and International Trade
5. International Rett Syndrome Foundation chief science officer receives prestigious military awards
6. Wayne State receives grant to reduce emissions of toxins by power plants into Great Lakes
7. UCSF receives $4.5M to study value of gene sequencing in newborns
8. Wistar receives $1.5 million Department of Defense grant to ready prostate drug for clinical use
9. Garvan Institute receives grant to research role of long non-coding RNAs in Parkinsons disease
10. SOFIE BIO Receives $1.8M Phase II SBIR Grant
11. AgriLife researcher Xiuren Zhang receives National Science Foundation CAREER grant
Post Your Comments:
(Date:4/5/2017)... NEW YORK , April 5, 2017 ... security, is announcing that the server component of the ... is known for providing the end-to-end security architecture that ... customers. HYPR has already secured over 15 ... system makers including manufacturers of connected home product suites ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... Rosalind™, the first-ever genomics analysis platform specifically designed for life science researchers ... honor of pioneering researcher Rosalind Franklin, who made a major contribution to ...
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
Breaking Biology Technology: